These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 28685207)

  • 1. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
    Borggrefe MM; Lawo T; Butter C; Schmidinger H; Lunati M; Pieske B; Misier AR; Curnis A; Böcker D; Remppis A; Kautzner J; Stühlinger M; Leclerq C; Táborsky M; Frigerio M; Parides M; Burkhoff D; Hindricks G
    Eur Heart J; 2008 Apr; 29(8):1019-28. PubMed ID: 18270213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac contractility modulation in heart failure patients: Randomized comparison of signal delivery through one vs. two ventricular leads.
    Röger S; Said S; Kloppe A; Lawo T; Emig U; Rousso B; Gutterman D; Borggrefe M; Kuschyk J
    J Cardiol; 2017 Jan; 69(1):326-332. PubMed ID: 27590412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study.
    Liu M; Fang F; Luo XX; Shlomo BH; Burkhoff D; Chan JY; Chan CP; Cheung L; Rousso B; Gutterman D; Yu CM
    Int J Cardiol; 2016 Mar; 206():122-6. PubMed ID: 26788686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
    Kuschyk J; Nägele H; Heinz-Kuck K; Butter C; Lawo T; Wietholt D; Roeger S; Gutterman D; Burkhoff D; Rousso B; Borggrefe M
    Int J Cardiol; 2019 Feb; 277():173-177. PubMed ID: 30409733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of baseline left ventricular ejection fraction on long-term outcomes in cardiac contractility modulation therapy.
    Yücel G; Fastner C; Hetjens S; Toepel M; Schmiel G; Yazdani B; Husain-Syed F; Liebe V; Rudic B; Akin I; Borggrefe M; Kuschyk J
    Pacing Clin Electrophysiol; 2022 May; 45(5):639-648. PubMed ID: 35262210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure.
    Schau T; Seifert M; Meyhöfer J; Neuss M; Butter C
    Europace; 2011 Oct; 13(10):1436-44. PubMed ID: 21712286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system.
    Kuschyk J; Falk P; Demming T; Marx O; Morley D; Rao I; Burkhoff D
    Eur J Heart Fail; 2021 Jul; 23(7):1160-1169. PubMed ID: 34002440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction.
    Röger S; Rudic B; Akin I; Shchetynska-Marinova T; Fastenrath F; Tülümen E; Liebe V; El-Battrawy I; Baumann S; Kuschyk J; Borggrefe M
    Clin Cardiol; 2018 Apr; 41(4):518-524. PubMed ID: 29697870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
    Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration.
    Neelagaru SB; Sanchez JE; Lau SK; Greenberg SM; Raval NY; Worley S; Kalman J; Merliss AD; Krueger S; Wood M; Wish M; Burkhoff D; Nademanee K
    Heart Rhythm; 2006 Oct; 3(10):1140-7. PubMed ID: 17018340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac contractility modulation in left ventricular systolic dysfunction: one-year experience in a pilot study and design of a prospective registry.
    Matta M; Devecchi C; DE Vecchi F; Barbonaglia L; Gravellone M; Occhetta E; Rametta F
    Minerva Cardiol Angiol; 2021 Feb; 69(1):15-24. PubMed ID: 32657553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.
    Yu CM; Chan JY; Zhang Q; Yip GW; Lam YY; Chan A; Burkhoff D; Lee PW; Fung JW
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1341-9. PubMed ID: 20083066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive servo-ventilation to treat central sleep apnea in heart failure with reduced ejection fraction: the Bad Oeynhausen prospective ASV registry.
    Oldenburg O; Wellmann B; Bitter T; Fox H; Buchholz A; Freiwald E; Horstkotte D; Wegscheider K
    Clin Res Cardiol; 2018 Aug; 107(8):719-728. PubMed ID: 29654439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
    Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
    Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
    Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
    J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.